Intrinsiqs

Is Pelthos Therapeutics Inc. overvalued?

Pelthos Therapeutics Inc. (PTHS) — key valuation metrics and fundamentals.

No verdict
Price
$28.34
Fair value
Current P/E
Normal P/E
Market cap
$94.6M
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares PTHS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 13 Aug 2026.